Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03344965
Title Olaparib In Metastatic Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Dana-Farber Cancer Institute
Indications

breast cancer

Therapies

Olaparib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Recruiting Birmingham Alabama 35294 United States Details
University of California, San Francisco Recruiting San Francisco California 94143 United States Details
University of Chicago Recruiting Chicago Illinois 60637 United States Details
Indiana University Active, not recruiting Indianapolis Indiana 46202 United States Details
Johns Hopkins University Recruiting Baltimore Maryland 21218 United States Details
Beth Israel Deaconess Medical Center Recruiting Boston Massachusetts 02115 United States Details
Brigham and Women's Hospital Recruiting Boston Massachusetts 02115 United States Details
Dana-Farber Cancer Institute Recruiting Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering Cancer Center Recruiting New York New York 10065 United States Details
Duke University Recruiting Durham North Carolina 27708 United States Details
University of Pennsylvania Recruiting Philadelphia Pennsylvania 19104 United States Details
University of Pittsburgh Recruiting Pittsburgh Pennsylvania 15260 United States Details
University of Washington Seattle Cancer Care Alliance Recruiting Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field